NCT06405607View on ClinicalTrials.gov

Psilocybin vs Ketamine for Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 12, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Alcohol Use DisorderAlcohol DependenceAlcohol Abuse
Interventions
DRUG

Psilocybin

30 mg single dose

DRUG

Ketamine

0.75 mg/kg weight-based single dose

Trial Locations (1)

52240

RECRUITING

University of Iowa Health Care, Iowa City

All Listed Sponsors
lead

University of Iowa

OTHER

NCT06405607 - Psilocybin vs Ketamine for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter